Navigation Links
PurinaCare(R) Pet Health Insurance Now Helping Protect Dogs and Cats in California
Date:4/22/2009

b>About PurinaCare Insurance Services, Inc.

PurinaCare Insurance Services, Inc. (PISI) is a wholly-owned subsidiary of Nestle Purina PetCare Company - one of the leading global players in the pet food industry. As part of the Nestle Purina PetCare family, PISI promotes responsible pet care, humane education, community involvement and the positive bond between people and their pets. PISI markets and sells PurinaCare(R) policies as a licensed insurance agency. www.purinacare.com


'/>"/>
SOURCE PurinaCare Insurance Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. KGBTexas Named Public Relations Agency of Record for PurinaCare(R) Pet Health Insurance
2. New PurinaCare(R) Pet Health Library Helps Pet Owners Provide a Lifetime of Health and Happiness for Their Dogs and Cats
3. SCAN Health Plan Partners With Local Station ABC 15 to Provide Healthy Living Tips and Resources to Area Seniors
4. Baycare Health System Hospital Earns National Recognition
5. Palliative care skills training needed for health-care staff in sub-Saharan Africa
6. Netsmart Technologies Announces Partnership With Health Information Exchange Consulting Firm Object Health
7. Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals
8. Three Million People Now Using Kaiser Permanentes Personal Health Record
9. Millennials Push For Seat at the Table on Healthcare Reform
10. Family Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR
11. West Penn Allegheny Health System Files Lawsuit Charging UPMC, Highmark with Conspiracy, Antitrust
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Tim Russert's Death Provides Important Opportunity for News Media to Increase Public Awareness of How to Prevent Sudden Cardiac Arrest 2Health News:Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx 2Health News:Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx 3Health News:Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx 4Health News:ENADA NADH Is Back 2Health News:Nutrition 21 Introduces New Product: Iceland Health Skin Rejuvenation(TM) 2Health News:Nutrition 21 Introduces New Product: Iceland Health Skin Rejuvenation(TM) 3Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 2Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 3Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 4
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5OncoGenex Reports Third Quarter 2009 Financial Results 14740 1OncoGenex Reports Third Quarter 2009 Financial Results 14740 2OncoGenex Reports Third Quarter 2009 Financial Results 14740 3OncoGenex Reports Third Quarter 2009 Financial Results 14740 4OncoGenex Reports Third Quarter 2009 Financial Results 14740 5OncoGenex Reports Third Quarter 2009 Financial Results 14740 6OncoGenex Reports Third Quarter 2009 Financial Results 14740 7OncoGenex Reports Third Quarter 2009 Financial Results 14740 8Cepheid to Webcast Upcoming Financial Presentations 14737 1Cepheid to Webcast Upcoming Financial Presentations 14737 2MAGNET Selects DOTmed com to Assist Members in Sale of Used Medical Equipment and Idle Assets 6033 1MAGNET Selects DOTmed com to Assist Members in Sale of Used Medical Equipment and Idle Assets 6033 2